Glucose Tolerance Test Market Size, Share, Growth Analysis, By Product(Smart Sensor, Blood Glucose Testing Kit, Meters, Test Slips and Other), By Disease Indication(Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance), By End User(Hospitals, Home, Diagnostic Clinic, and Others), By Region - Industry Forecast 2024-2031


Report ID: SQMIG35D2225 | Region: Global | Published Date: April, 2024
Pages: 213 |Tables: 94 |Figures: 71

Glucose Tolerance Test Market Insights

Global Glucose Tolerance Test Market size was valued at USD 25603 million in 2022, USD 27110 million in 2023 and is projected to grow USD 41750 million by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The market is expanding due to rising diabetes rates, technical developments, and rising public awareness of the benefits of point-of-care glucose testing. With the growing popularity of needle-free blood glucose monitoring devices, many major players are providing patients with painless diabetes care. Recently, the Clinical & Laboratories Standard Institute, an international organization, standardized the accuracy guidelines for point-of-care glucose testing. Using the POCT device is common in the critical care unit. POC testing has become more necessary in recent years.

Also, it is anticipated that the need for glucose diagnostics would rise due to the unmet medical needs for diabetes diagnosis and management and the rise in patient awareness. The International Diabetes Federation estimates that 537 million people worldwide have diabetes in 2021; by 2030, that figure is expected to rise to 643 million, and by 2045, it is expected to reach 783 million. The need for Short Turn-Around Testing (STAT) has surged because of the healthcare industry's emphasis on improved acute care, shorter hospital stays, and the growth of outlying surgical centers. Solutions for managing glucose tests make it simple for patients and medical professionals to gather, share, and keep track of specimens to comply with legal obligations.

Market Snapshot - 2024-2031

Global Market Size

USD 25603 million

Largest Segment

Blood glucose testing kit

Fastest Growth

Smart sensor

Growth Rate

5.9% CAGR

Global Glucose Tolerance Market ($ Bn)
Country Share by North America (%)

To get more reports on the above market click here to Buy The Report

Glucose Tolerance Test Market Segmental Analysis

The global glucose tolerance test market is segmented based on product type, disease indication type, end user and regional type. In terms of product type, the market is segmented into smart sensors, blood glucose testing kit, meters, test slips and others. Based on end user, the market is bifurcated into hospitals, home, diagnostic clinics and others. Based on disease indication, the market is bifurcated into reactive hypoglycemia, diabetes hypoglycemia, gestational diabetes, insulin resistance and others. Based on region, the market is segmented into North America, Europe, Asia Pacific, Central & South America and Middle East & Africa. The product segment's potential to improve patient outcomes and lessen the cost of healthcare is what will drive its future growth.

Analysis by Product

As per categorization by product, the market is classified into smart sensors, blood glucose testing kit, meters, test slips and others. Among these, blood glucose testing kit earned the largest share and continues to dominate the market. The global market for glucose tolerance tests is undergoing a revolution thanks to advancements in smart sensor technology, especially in blood glucose testing kits. These sensors improve the precision and effectiveness of glucose tolerance testing by providing real-time monitoring and data collection. These devices' IoT connection makes it possible for them to link to other devices or smartphones with ease, giving users the ability to properly control their blood sugar levels. These developments have the potential to enhance diabetes care and improve global health outcomes.

Due to the number of variables, meters, test strips, and other relevant accessories, it is expected to increase at the quickest rate in the global glucose tolerance test market. First off, the need for glucose monitoring equipment and supplies is being driven by the growing incidence of diabetes worldwide. Furthermore, technological developments have resulted in the creation of more precise and user-friendly meters and test strips, increasing their attractiveness to customers. Furthermore, the adoption of these accessories is being driven by a greater understanding of the significance of routine blood glucose monitoring for the management of diabetes, which is further propelling market expansion.

Analysis by Disease Indication

By tackling the challenges of hypoglycemia diagnosis and management, innovations in reactive hypoglycemia and diabetes hypoglycemia detection are altering the global market for glucose tolerance tests. More precise and prompt diagnosis of hypoglycemic episodes is made possible by advanced testing procedures, such as rapid-acting glucose tests and continuous glucose monitoring devices. This is especially important for those with reactive hypoglycemia or diabetes. By enabling early intervention and individualized treatment plans, these breakthroughs improve patient outcomes and stimulate market expansion.

Due to several important variables, the global glucose tolerance test market is expected to develop at the fastest rate in the categories of gestational diabetes, insulin resistance, and related disorders. First, there is a growing global demand for glucose tolerance testing during pregnancy due to variables including increased obesity rates and mother age contributing to gestational diabetes. Furthermore, the increasing awareness of the dangers of insulin resistance and its connection to metabolic diseases like polycystic ovarian syndrome (PCOS) is encouraging at-risk groups to use glucose tolerance testing, which is propelling the market's expansion.

Global Glucose Tolerance Market By Product (%)

To get detailed analysis on other segments, Request For Free Sample Report

Glucose Tolerance Test Market Regional Insights

The North American region dominates the global market since it holds the biggest market share in the industry. The rising cost of healthcare, the rise in diabetes cases, and the acceleration of technological advancements are the causes of this. The European area holds the second-largest market share in the global market. The Eastern European and Western European regions are further divisions of this region. Western European nations include France, Germany, Spain, Italy, and the United Kingdom. The ageing population, improved research and development, and healthcare infrastructure all contribute to the market's expansion. The utilization of glucose tolerance tests is being propelled by advancements in healthcare infrastructure and heightened consciousness regarding the need for prompt diagnosis and management of diabetes.

Due to its rapid growth, the Asia-Pacific region holds the third-largest market share in the worldwide glucose tolerance test market. Due to the high population density of this region's countries, there are several growth prospects for the projected future. Another important factor is the advancements made in the healthcare industry. According to regional insights, the fastest-growing segments of the global glucose tolerance test market are developing from Latin America, the Middle East, and Africa. The rising prevalence of diabetes and associated metabolic problems in these areas is attributed to many factors, including fast urbanization, shifting food preferences, and sedentary lifestyles. As a result, this sector is seeing tremendous market growth across Latin America, the Middle East, and Africa.

Global Glucose Tolerance Market By Geography
  • Largest
  • Fastest

To know more about the market opportunities by region and country, click here to
Buy The Complete Report

Glucose Tolerance Test Market Dynamics

Drivers

Increasing Rate of Diabetes

  • The rising incidence of diabetes worldwide is a major factor behind the expansion of the global market for glucose tolerance tests. The rise in diabetes incidence can be attributed to changes in lifestyle, such as sedentary behaviour and poor food, which raises the need for efficient diagnostic instruments like glucose tolerance testing. These tests are becoming more and more popular due to their critical role in the early diagnosis and treatment of diabetes.

Technological Progress

  • The global glucose tolerance test market is expanding because of technological advancements in testing procedures and glucose monitoring equipment. The efficiency and efficacy of glucose tolerance tests are being improved by ongoing developments such as the creation of glucose metres that are more accurate and easier to use, the incorporation of IoT capabilities for real-time data monitoring, and the introduction of minimally invasive testing techniques. These developments enhance patient experience while also fostering market expansion through increased accessibility and applicability.

Restraints

Excessive Testing Costs

  • One of the main factors impeding the growth of the global glucose tolerance test market is the high cost of these tests. Many people still struggle with affordability, especially in poorer nations where healthcare funding is scarce. Growth in the market may be restricted if patients are discouraged from undergoing essential diagnostic procedures due to the costs associated with glucose testing kits, metres, and related accessories, as well as the requirement for frequent testing.

Restricted Access to Medical Services

  • One major obstacle to the growth of the global glucose tolerance test market is the lack of access to healthcare services, especially in underdeveloped and rural areas. The lack of educated healthcare personnel, inadequate infrastructure, and low awareness of diabetes screening are some of the factors that make it difficult to obtain glucose tolerance tests. This restriction impedes the prompt diagnosis and treatment of diabetes, impeding market growth and affecting the general state of public health.

Request Free Customization of this report to help us to meet your business objectives.

Glucose Tolerance Test Market Competitive Landscape

The market is extremely fragmented, with a significant number of medium-, small-, and big-sized providers. Key multinational players that are attempting to innovate and broaden their market reach are what define the competitive landscape of the global glucose tolerance test market. Prominent players in this field include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care Holdings AG. These businesses make constant investments in R&D to bring cutting-edge glucose monitoring technologies to the market and expand their product lines, which increases competition and spurs market expansion.

Top Player’s Company Profiles

  • Johnson & Johnson Inc (US)
  • Bayer AG (Germany)
  • Panasonic (Japan)
  • Sanofi (France)
  • Penlan Healthcare Ltd. (UK)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • E-Zlab Health Services (Canada)
  • Abbott Labs (US)
  • Laboratory Corporation of American Holdings (US)
  • Lifescan IP Holdings (US)
  • F.Hoffman-La Roche Ltd. (Switzerland)
  • Dexcom, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Quest Diagnostics Incorporated (US)
  • Merck KGaA (Germany)

Recent Developments

  • In November 2020, In Europe, Roche Diagnostics' Accu-Chek SugarView app was approved with the CE Mark. Through images of their test strips, users of this cutting-edge smartphone software may visually estimate their blood sugar levels, improving accessibility and ease for managing their diabetes.
  • In April 2020, to combine Dexcom continuous glucose monitoring (CGM) data with Lilly's linked insulin delivery devices, Dexcom Inc. and Eli Lilly established a partnership. By giving people access to real-time glucose monitoring and insulin dosing insights, this partnership seeks to simplify the management of diabetes and may even enhance treatment results.
  • In September 2021, The US launch of Abbott Laboratories' FreeStyle Libre 2 system was announced. This cutting-edge continuous glucose monitoring device provides real-time glucose readings, adjustable hyperglycemia and hypoglycemia alerts, and optional alarms that can be used with a compatible smartphone or reader.

Glucose Tolerance Test Key Market Trends

  • Advancements in Diagnostic Technologies: Recent years have witnessed notable trends and developments in the glucose tolerance test (GTT) industry, which can be attributed to shifts in healthcare policies, improvements in diagnostic tools, and changing patient demands. One noteworthy trend is the global rise in the prevalence of diabetes and prediabetes, which is being caused by ageing populations, bad diets, and sedentary lifestyles. The need for precise and trustworthy diagnostic tools, like the GTT, to identify those at risk and enable early intervention and management of the condition is increasing as the incidence of diabetes rises. The GTT market is expanding because of this trend, as healthcare professionals try to keep up with the rising demand for diabetes diagnosis and screening.
  • Comprehensive Approach with Integrated CGM System: Continuous glucose monitoring (CGM) systems offer long-term glucose data that can be used for in-depth investigation of postprandial excursions, nocturnal glycemia patterns, and glucose variability. When CGM data and GTT results are combined, a comprehensive understanding of insulin dynamics and glucose metabolism is provided. This helps people with diabetes and impaired glucose tolerance receive individualized treatment plans and lifestyle modifications. Furthermore, improvements in smartphone-based glucose monitoring apps and wearable glucose sensors increase patient convenience and self-management of diabetes.

Glucose Tolerance Test Market SkyQuest Analysis

SkyQuest’s ABIRAW (Advanced Business Intelligence, Research & Analysis Wing) is our Business Information Services team that Collects, Collates, Correlates, and Analyses the Data collected by means of Primary Exploratory Research backed by robust Secondary Desk research.

As per SkyQuest analysis, due to changes in lifestyle that are causing diabetes to become more commonplace globally, the need for effective diagnostic tools like glucose tolerance testing is driving the growth of the global market for glucose tolerance tests. The efficiency and accessibility of glucose tolerance tests are being improved by technological developments in glucose monitoring equipment, such as more precise meters and real-time data monitoring capabilities, which is driving market expansion. Due to the high expense of testing, especially in developing nations, the global market for glucose tolerance tests is expected to grow slowly. This could limit patient access to necessary diagnostic treatments and impede market progress.

Multinational corporations like Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care Holdings AG dominate the market and drive competition through innovation, a strong market presence, and ongoing investments in research and development to expand product lines and spur market growth. The global glucose tolerance test market is fragmented, with numerous providers ranging in size from medium to large. The market is developing due to the increasing need for accurate diagnostic tools such as GTT to enable early intervention and treatment. Healthcare professionals are driving this demand by attempting to fulfil the rising need for diabetes screening and diagnosis. With wearable sensors and smartphone-based monitoring apps, this provides a holistic approach to diabetes care, enabling customized treatment programmes and improving patient convenience.

Report Metric Details
Market size value in 2023 USD 25603 million
Market size value in 2031 USD 41750 million
Growth Rate 5.9%
Forecast period 2024-2031
Forecast Unit (Value) USD Million
Segments covered
  • Product
    • Smart Sensor, Blood Glucose Testing Kit, Meters, Test Slips and Other
  • Disease Indication
    • Reactive Hypoglycemia, Diabetes Hypoglycemia, Gestational Diabetes, Insulin Resistance, and Others
  • End User
    • Hospitals, Home, Diagnostic Clinic, and Others
Regions covered North America (US, Canada), Europe (Germany, France, United Kingdom, Italy, Spain, Rest of Europe), Asia Pacific (China, India, Japan, Rest of Asia-Pacific), Latin America (Brazil, Rest of Latin America), Middle East & Africa (South Africa, GCC Countries, Rest of MEA)
Companies covered
  • Johnson & Johnson Inc (US)
  • Bayer AG (Germany)
  • Panasonic (Japan)
  • Sanofi (France)
  • Penlan Healthcare Ltd. (UK)
  • Ascensia Diabetes Care Holdings AG (Switzerland)
  • E-Zlab Health Services (Canada)
  • Abbott Labs (US)
  • Laboratory Corporation of American Holdings (US)
  • Lifescan IP Holdings (US)
  • F.Hoffman-La Roche Ltd. (Switzerland)
  • Dexcom, Inc. (US)
  • Thermo Fisher Scientific Inc. (US)
  • Quest Diagnostics Incorporated (US)
  • Merck KGaA (Germany)
Customization scope

Free report customization with purchase. Customization includes:-

  • Segments by type, application, etc
  • Company profile
  • Market dynamics & outlook
  • Region

To get a free trial access to our platform which is a one stop solution for all your data requirements for quicker decision making. This platform allows you to compare markets, competitors who are prominent in the market, and mega trends that are influencing the dynamics in the market. Also, get access to detailed SkyQuest exclusive matrix.

Buy The Complete Report to read the analyzed strategies adopted by the top vendors either to retain or gain market share

Table Of Content

Executive Summary

Market overview

  • Exhibit: Executive Summary – Chart on Market Overview
  • Exhibit: Executive Summary – Data Table on Market Overview
  • Exhibit: Executive Summary – Chart on Glucose Tolerance Test Market Characteristics
  • Exhibit: Executive Summary – Chart on Market by Geography
  • Exhibit: Executive Summary – Chart on Market Segmentation
  • Exhibit: Executive Summary – Chart on Incremental Growth
  • Exhibit: Executive Summary – Data Table on Incremental Growth
  • Exhibit: Executive Summary – Chart on Vendor Market Positioning

Parent Market Analysis

Market overview

Market size

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • SWOT Analysis

KEY MARKET INSIGHTS

  • Technology Analysis
    • (Exhibit: Data Table: Name of technology and details)
  • Pricing Analysis
    • (Exhibit: Data Table: Name of technology and pricing details)
  • Supply Chain Analysis
    • (Exhibit: Detailed Supply Chain Presentation)
  • Value Chain Analysis
    • (Exhibit: Detailed Value Chain Presentation)
  • Ecosystem Of the Market
    • Exhibit: Parent Market Ecosystem Market Analysis
    • Exhibit: Market Characteristics of Parent Market
  • IP Analysis
    • (Exhibit: Data Table: Name of product/technology, patents filed, inventor/company name, acquiring firm)
  • Trade Analysis
    • (Exhibit: Data Table: Import and Export data details)
  • Startup Analysis
    • (Exhibit: Data Table: Emerging startups details)
  • Raw Material Analysis
    • (Exhibit: Data Table: Mapping of key raw materials)
  • Innovation Matrix
    • (Exhibit: Positioning Matrix: Mapping of new and existing technologies)
  • Pipeline product Analysis
    • (Exhibit: Data Table: Name of companies and pipeline products, regional mapping)
  • Macroeconomic Indicators

COVID IMPACT

  • Introduction
  • Impact On Economy—scenario Assessment
    • Exhibit: Data on GDP - Year-over-year growth 2016-2022 (%)
  • Revised Market Size
    • Exhibit: Data Table on Glucose Tolerance Test Market size and forecast 2021-2027 ($ million)
  • Impact Of COVID On Key Segments
    • Exhibit: Data Table on Segment Market size and forecast 2021-2027 ($ million)
  • COVID Strategies By Company
    • Exhibit: Analysis on key strategies adopted by companies

MARKET DYNAMICS & OUTLOOK

  • Market Dynamics
    • Exhibit: Impact analysis of DROC, 2021
      • Drivers
      • Opportunities
      • Restraints
      • Challenges
  • Regulatory Landscape
    • Exhibit: Data Table on regulation from different region
  • SWOT Analysis
  • Porters Analysis
    • Competitive rivalry
      • Exhibit: Competitive rivalry Impact of key factors, 2021
    • Threat of substitute products
      • Exhibit: Threat of Substitute Products Impact of key factors, 2021
    • Bargaining power of buyers
      • Exhibit: buyers bargaining power Impact of key factors, 2021
    • Threat of new entrants
      • Exhibit: Threat of new entrants Impact of key factors, 2021
    • Bargaining power of suppliers
      • Exhibit: Threat of suppliers bargaining power Impact of key factors, 2021
  • Skyquest special insights on future disruptions
    • Political Impact
    • Economic impact
    • Social Impact
    • Technical Impact
    • Environmental Impact
    • Legal Impact

Market Size by Region

  • Chart on Market share by geography 2021-2027 (%)
  • Data Table on Market share by geography 2021-2027(%)
  • North America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • USA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Canada
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Europe
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Germany
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Spain
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • France
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • UK
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Europe
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Asia Pacific
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • China
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • India
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Japan
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Korea
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of Asia Pacific
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Latin America
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • Brazil
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of South America
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
  • Middle East & Africa (MEA)
    • Chart on Market share by country 2021-2027 (%)
    • Data Table on Market share by country 2021-2027(%)
    • GCC Countries
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • South Africa
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)
    • Rest of MEA
      • Exhibit: Chart on Market share 2021-2027 (%)
      • Exhibit: Market size and forecast 2021-2027 ($ million)

KEY COMPANY PROFILES

  • Competitive Landscape
    • Total number of companies covered
      • Exhibit: companies covered in the report, 2021
    • Top companies market positioning
      • Exhibit: company positioning matrix, 2021
    • Top companies market Share
      • Exhibit: Pie chart analysis on company market share, 2021(%)

Methodology

For the Glucose Tolerance Test Market, our research methodology involved a mixture of primary and secondary data sources. Key steps involved in the research process are listed below:

1. Information Procurement: This stage involved the procurement of Market data or related information via primary and secondary sources. The various secondary sources used included various company websites, annual reports, trade databases, and paid databases such as Hoover's, Bloomberg Business, Factiva, and Avention. Our team did 45 primary interactions Globally which included several stakeholders such as manufacturers, customers, key opinion leaders, etc. Overall, information procurement was one of the most extensive stages in our research process.

2. Information Analysis: This step involved triangulation of data through bottom-up and top-down approaches to estimate and validate the total size and future estimate of the Glucose Tolerance Test Market.

3. Report Formulation: The final step entailed the placement of data points in appropriate Market spaces in an attempt to deduce viable conclusions.

4. Validation & Publishing: Validation is the most important step in the process. Validation & re-validation via an intricately designed process helped us finalize data points to be used for final calculations. The final Market estimates and forecasts were then aligned and sent to our panel of industry experts for validation of data. Once the validation was done the report was sent to our Quality Assurance team to ensure adherence to style guides, consistency & design.

Analyst Support

Customization Options

With the given market data, our dedicated team of analysts can offer you the following customization options are available for the Glucose Tolerance Test Market:

Product Analysis: Product matrix, which offers a detailed comparison of the product portfolio of companies.

Regional Analysis: Further analysis of the Glucose Tolerance Test Market for additional countries.

Competitive Analysis: Detailed analysis and profiling of additional Market players & comparative analysis of competitive products.

Go to Market Strategy: Find the high-growth channels to invest your marketing efforts and increase your customer base.

Innovation Mapping: Identify racial solutions and innovation, connected to deep ecosystems of innovators, start-ups, academics, and strategic partners.

Category Intelligence: Customized intelligence that is relevant to their supply Markets will enable them to make smarter sourcing decisions and improve their category management.

Public Company Transcript Analysis: To improve the investment performance by generating new alpha and making better-informed decisions.

Social Media Listening: To analyze the conversations and trends happening not just around your brand, but around your industry as a whole, and use those insights to make better Marketing decisions.

$5,300
BUY NOW

REQUEST FOR SAMPLE

Want to customize this report?
REQUEST FREE CUSTOMIZATION

FAQs

Glucose Tolerance Test Market size was valued at USD 25603 million in 2022, USD 27110 million in 2023 and is projected to grow USD 41750 million by 2031, growing at a CAGR of 5.9% in the forecast period (2024-2031).

The market is extremely fragmented, with a significant number of medium-, small-, and big-sized providers. Key multinational players that are attempting to innovate and broaden their market reach are what define the competitive landscape of the glucose tolerance test market. Prominent players in this field include Abbott Laboratories, Roche Diagnostics, Dexcom Inc., Medtronic plc, and Ascensia Diabetes Care Holdings AG. These businesses make constant investments in R&D to bring cutting-edge glucose monitoring technologies to the market and expand their product lines, which increases competition and spurs market expansion. 'Johnson & Johnson Inc (US)', 'Bayer AG (Germany)', 'Panasonic (Japan)', 'Sanofi (France)', 'Penlan Healthcare Ltd. (UK)', 'Ascensia Diabetes Care Holdings AG (Switzerland)', 'E-Zlab Health Services (Canada)', 'Abbott Labs (US)', 'Laboratory Corporation of American Holdings (US)', 'Lifescan IP Holdings (US)', 'F.Hoffman-La Roche Ltd. (Switzerland)', 'Dexcom, Inc. (US)', 'Thermo Fisher Scientific Inc. (US)', 'Quest Diagnostics Incorporated (US)', 'Merck KGaA (Germany)'

The rising incidence of diabetes worldwide is a major factor behind the expansion of the market for glucose tolerance tests. The rise in diabetes incidence can be attributed to changes in lifestyle, such as sedentary behaviour and poor food, which raises the need for efficient diagnostic instruments like glucose tolerance testing. These tests are becoming more and more popular due to their critical role in the early diagnosis and treatment of diabetes.

Advancements in Diagnostic Technologies: Recent years have witnessed notable trends and developments in the glucose tolerance test (GTT) industry, which can be attributed to shifts in healthcare policies, improvements in diagnostic tools, and changing patient demands. One noteworthy trend is the rise in the prevalence of diabetes and prediabetes, which is being caused by ageing populations, bad diets, and sedentary lifestyles. The need for precise and trustworthy diagnostic tools, like the GTT, to identify those at risk and enable early intervention and management of the condition is increasing as the incidence of diabetes rises. The GTT market is expanding because of this trend, as healthcare professionals try to keep up with the rising demand for diabetes diagnosis and screening.

The North American region dominates the market since it holds the biggest market share in the industry. The rising cost of healthcare, the rise in diabetes cases, and the acceleration of technological advancements are the causes of this. The European area holds the second-largest market share in the market. The Eastern European and Western European regions are further divisions of this region. Western European nations include France, Germany, Spain, Italy, and the United Kingdom. The ageing population, improved research and development, and healthcare infrastructure all contribute to the market's expansion. The utilization of glucose tolerance tests is being propelled by advancements in healthcare infrastructure and heightened consciousness regarding the need for prompt diagnosis and management of diabetes.

Request Free Customization

Want to customize this report? This report can be personalized according to your needs. Our analysts and industry experts will work directly with you to understand your requirements and provide you with customized data in a short amount of time. We offer $1000 worth of FREE customization at the time of purchase.

logo-images

Feedback From Our Clients

Glucose Tolerance Test Market

Report ID: SQMIG35D2225

sales@skyquestt.com
USA +1 351-333-4748

BUY NOW GET FREE SAMPLE